Drug identification and interaction checker based on IoT to minimize adverse drug reactions and improve drug compliance

Authors:
Antonio J. Jara;Miguel A. Zamora;Antonio F. Skarmeta
Affiliations:
Clinical Technology Lab, Computer Science Fac, University of Murcia, Murcia, Spain;Clinical Technology Lab, Computer Science Fac, University of Murcia, Murcia, Spain;Clinical Technology Lab, Computer Science Fac, University of Murcia, Murcia, Spain
Venue:
Personal and Ubiquitous Computing
Year:
2014

Citing 3
Cited 3

The Internet of Things: A survey

Computer Networks: The International Journal of Computer and Telecommunications Networking
An internet of things---based personal device for diabetes therapy management in ambient assisted living (AAL)

Personal and Ubiquitous Computing
An exposure system for evaluating possible effects of RFID on various formulations of drug products [Supplement, Applications & Practice]

IEEE Communications Magazine - Part Supplement

Mobile digcovery: discovering and interacting with the world through the Internet of things

Personal and Ubiquitous Computing
Assistive environments for the disabled and the senior citizens: theme issue of PETRA 2010 and 2011 conferences

Personal and Ubiquitous Computing
Participative marketing: extending social media marketing through the identification and interaction capabilities from the Internet of things

Personal and Ubiquitous Computing

Quantified Score

Hi-index	0.00

Visualization

Abstract

Drug compliance and adverse drug reactions (ADR) are two of the most important issues regarding patient safety throughout the worldwide healthcare sector. ADR prevalence is 6.7 % throughout hospitals worldwide, with an international death rate of 0.32 % of the total of the patients. This rate is even higher in Ambient Assisted Living environments, where 15 % of the patients suffer clinically significant interactions due to patient non-compliance to drug dosage and schedule of intake in addition to suffering from polypharmacy. These instances increase with age and cause risks of drug interactions, adverse effects, and toxicity. However, with a tight follow-up of the drug treatment, complications of incorrect drug use can be reduced. For that purpose, we propose an innovative system based on the Internet of Things (IoT) for the drug identification and the monitoring of medication. IoT is applied to examine drugs in order to fulfill treatment, to detect harmful side effects of pharmaceutical excipients, allergies, liver/renal contradictions, and harmful side effects during pregnancy. The IoT design acknowledges that the aforementioned problems are worldwide so the solution supports several IoT identification technologies: barcode, Radio Frequency Identification, Near Field Communication, and a new solution developed for low-income countries based on IrDA in collaboration with the World Health Organization. These technologies are integrated in personal devices such as smart-phones, PDAs, PCs, and in our IoT-based personal healthcare device called Movital.